Media Room

December 6, 2022

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

December 1, 2022

Assessing Adaptive Immune Responses to Viruses to Inform Decisions about Vaccinations with Dr. Tomasz George

By Karen Jagoda

November 23, 2022

In Every Crisis There Is An Opportunity – Interview with Chief Executive, James Foster

by Tom Hickey

November 15, 2022

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

November 8, 2022

Virax Biolabs Announces Closing of $3.8 Million Private Placement

November 4, 2022

Virax Biolabs Announces $3.8 Million Private Placement

November 3, 2022

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

October 26, 2022

Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

September 30, 2022

Monkeypox Diagnosis and Immune Profiling Using Proprietary T-cell Test Technology

September 22, 2022

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

September 20, 2022

Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

September 12, 2022

Virax Biolabs Presents at H.C. Wainwright’s 24th Annual Global Investment Conference